| Identification | Back Directory | [Name]
4-Piperidinecarboxylic acid, 1-[[4-[5-[3-chloro-4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-[(2-methoxyethoxy)methyl]- | [CAS]
1403232-33-6 | [Synonyms]
SCD-044
Vibozilimod
vibozilimodum
4-Piperidinecarboxylic acid, 1-[[4-[5-[3-chloro-4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-[(2-methoxyethoxy)methyl]- | [Molecular Formula]
C29H36ClN3O5 | [MOL File]
1403232-33-6.mol | [Molecular Weight]
542.07 |
| Chemical Properties | Back Directory | [Boiling point ]
661.7±65.0 °C(Predicted) | [density ]
1.210±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Ethanol : 1.92 mg/mL (3.54 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60°C) | [form ]
Solid | [pka]
3.54±0.20(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Vibozilimod (SCD-044, example 33) is a S1p1 receptor agonist (extracted from patent WO2012140020A1)[1]. | [References]
[1] Marc Capet, et al. Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists. Patent. WO2012140020A1. |
|
| Company Name: |
ChemOrigin Pharm
|
| Tel: |
15026428026 19002516454 |
| Website: |
www.chemorigin.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|